This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2004 Feb;25(3):188-9.

doi: 10.1016/j.ehj.2003.10.014.

Prevention of contrast-induced renal dysfunction by N-acetylcysteine. Truth or myth?

M Billinger, O M Hess, B Meier

PMID: 14972417
DOI: 10.1016/j.ehj.2003.10.014

Editorial

Prevention of contrast-induced renal dysfunction by N-acetylcysteine. Truth or myth?

M Billinger et al. Eur Heart J. 2004 Feb.

. 2004 Feb;25(3):188-9.

doi: 10.1016/j.ehj.2003.10.014.

Authors

M Billinger, O M Hess, B Meier

PMID: 14972417
DOI: 10.1016/j.ehj.2003.10.014

No abstract available

PubMed Disclaimer

Comment on

Standard vs double dose of N-acetylcysteine to prevent contrast agent associated nephrotoxicity.
Briguori C, Colombo A, Violante A, Balestrieri P, Manganelli F, Paolo Elia P, Golia B, Lepore S, Riviezzo G, Scarpato P, Focaccio A, Librera M, Bonizzoni E, Ricciardelli B. Briguori C, et al. Eur Heart J. 2004 Feb;25(3):206-11. doi: 10.1016/j.ehj.2003.11.016. Eur Heart J. 2004. PMID: 14972420 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Medical
- MedlinePlus Health Information